
Please try another search
Investing.com -- Shares of Camurus AB climbed 5% following the company's fourth-quarter earnings release, which revealed a 2% revenue beat and a 23% profit before tax (PBT) beat compared to consensus...
On Tuesday, Rodman & Renshaw initiated coverage on shares of Indivior (NASDAQ: INDV) with a positive outlook, assigning a Buy rating and setting a price target of $16.00. The firm's analysts see...
On Wednesday, an analyst from Craig-Hallum adjusted the price target for Indivior (NASDAQ: INDV) shares, a pharmaceutical company, to $24 from the previous $37. Despite the change, the buy rating on...
Instrument Type
Region
Sector
Industry
Date
Category
Provider